Prevalence of emotional blunting and its association with childhood adverse experiences in depressive episodes.
BMC psychiatry · 2026
Abstract originale
BACKGROUND: Emotional blunting (EB) is common in patients with depressive episodes. This study aimed to study its prevalence in remitted and mild-to-moderate depressive episodes, and explore its association with adverse childhood experiences (ACEs). METHODS: This cross-sectional study included patients aged 18-65 years with mild depressive episodes in major depressive disorder (MDD), persistent depressive disorder (PDD), and bipolar disorder (BPD). EB and adverse childhood experiences were assessed using the Oxford Depression Questionnaire (ODQ) and the ACE questionnaire, respectively. The severity of depressive symptoms was measured using the Hamilton Depression Rating Scale (HAM-D). Statistical analyses used Pearson's correlation coefficients. RESULTS: A total of 106 participants completed the study. Prevalence of EB based on a single-question screening and ODQ cut-off score of ≥ 26 were 55.6%, and 89%, respectively. There were no significant differences in prevalence among diagnostic groups (p > 0.05). The prevalence was significantly lower in remitters (HAM-D ≤ 7) than non-remitters (45.3% vs. 66%, X2= 4.97, p < 0.05). Correlation analyses in entire sample showed significant correlations between the ODQ total score and HAM-D score, PHQ-9 score, and the number of depressive episodes (all p < 0.05). The Not Caring (NC) domain of the ODQ was positively correlated with ACE subscale scores for emotional abuse (r = 0.259, p = 0.007) and physical abuse (r = 0.208, p = 0.033), and negatively correlated with emotional support (r = - 0.25, p = 0.01). Subgroup analyses among remitters (n = 53) showed that NC scores were correlated with emotional abuse (r = 0.304, p = 0.027) and emotional support (r = - 0.328, p = 0.017). The emotional detachment (ED) domain of the ODQ was correlated with the ACE domestic violence subscale (r = 0.286, p = 0.038). CONCLUSION: EB was present in more than half of patients with depressive episodes. Remission was associated with a lower prevalence of EB; however, the prevalence remained high even among remitters. The severity of EB was correlated with the severity and recurrence of depressive symptoms. The Not Caring domain was associated with reported emotional abuse and domestic violence during childhood, even among remitted patients.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Prevalence of emotional blunting and its association with childhood adverse experiences in depressive episodes
Background
Emotional blunting (EB) is common in patients with depressive episodes. This study aimed to study its prevalence in remitted and mild-to-moderate depressive episodes, and explore its association with adverse childhood experiences (ACEs).
Methods
This cross-sectional study included patients aged 18–65 years with mild depressive episodes in major depressive disorder (MDD), persistent depressive disorder (PDD), and bipolar disorder (BPD). EB and adverse childhood experiences were assessed using the Oxford Depression Questionnaire (ODQ) and the ACE questionnaire, respectively. The severity of depressive symptoms was measured using the Hamilton Depression Rating Scale (HAM-D). Statistical analyses used Pearson’s correlation coefficients.
Results
A total of 106 participants completed the study. Prevalence of EB based on a single-question screening and ODQ cut-off score of ≥ 26 were 55.6%, and 89%, respectively. There were no significant differences in prevalence among diagnostic groups (p > 0.05). The prevalence was significantly lower in remitters (HAM-D ≤ 7) than non-remitters (45.3% vs. 66%, X2= 4.97, p < 0.05). Correlation analyses in entire sample showed significant correlations between the ODQ total score and HAM-D score, PHQ-9 score, and the number of depressive episodes (all p < 0.05). The Not Caring (NC) domain of the ODQ was positively correlated with ACE subscale scores for emotional abuse (r = 0.259, p = 0.007) and physical abuse (r = 0.208, p = 0.033), and negatively correlated with emotional support (r = − 0.25, p = 0.01). Subgroup analyses among remitters (n = 53) showed that NC scores were correlated with emotional abuse (r = 0.304, p = 0.027) and emotional support (r = − 0.328, p = 0.017). The emotional detachment (ED) domain of the ODQ was correlated with the ACE domestic violence subscale (r = 0.286, p = 0.038).
Conclusion
EB was present in more than half of patients with depressive episodes. Remission was associated with a lower prevalence of EB; however, the prevalence remained high even among remitters. The severity of EB was correlated with the severity and recurrence of depressive symptoms. The Not Caring domain was associated with reported emotional abuse and domestic violence during childhood, even among remitted patients.
Introduction
Major depression or major depressive disorder is one of the most common mental health disorders globally. It is estimated that approximately 332 million people worldwide currently live with depression, with roughly 5.7% of adults globally suffer from depression [1]. The pandemic of COVID-19 triggered a massive spike in global mental health struggles. Epidemiological models indicate that the global prevalence of Major Depressive Disorder (MDD) increased by roughly 27% in 2020 alone due to the stress, isolation, and socioeconomic impacts of the pandemic, and incidence rates have remained historically high in the years following [2]. While MDD can occur at any stage of life, incidence rates typically surge during adolescence and young adulthood (ages 15–29). MDD is a leading cause of Years Lived with Disability (YLDs) globally. Recent GBD data indicates that depressive disorders account for over 56 million Disability-Adjusted Life Years (DALYs) [3] worldwide [4]. Nearly 90% of individuals diagnosed with depression report significant difficulty managing work, home, or social activities due to their symptoms [5]. Depression is not a disorder with a single cause; rather, it stems from multifactorial influences, including neurobiological changes, genetic predisposition, physical health conditions, behavioral risks, and adverse life experiences. Childhood adverse experiences, including but not only abuse, neglect, bullying, and domestic violence are among the strongest predictive environmental risk factors for developing MDD [6], and associated with poor response and frequent recurrence [7, 8]. According to a meta-analysis, childhood trauma is common among patients with major depression, with a prevalence rate of up to 62% [9].
Emotional blunting (EB), characterized by a reduction in emotional responsiveness, is a significant phenomenon observed across various neurological and psychiatric conditions, particularly MDD [10]. EB is an umbrella term which covers apathy, amotivation, anhedonia, emotional numbness, and lack of empathy. Many patients with EB reported either childhood or recent psychological trauma [11]. Prevalence of EB in patients with MDD differs along the course of illness. During the acute phase of depression EB might be found up to 75–91.9%, while the prevalence declines to 25–73.3% after the treatment [10, 12].
The underlying neuropathology of emotional blunting (EB) is not yet well understood, but it is hypothesized to involve decreased dopaminergic or glutamatergic activity in the prefrontal cortex. This hypothesis aligns with the well-documented adverse effects of selective serotonin reuptake inhibitors (SSRIs), which include emotional indifference and an inability to cry [13, 14]. These experiences cause negative effects to overall well-being of the patients. A recent large web-based survey study from Japan demonstrated moderate correlation between EB and functional impairment [15], while another recent study from India found that up to 40% of patients considered stopping the antidepressant due to emotional blunting [16], which might led to medication discontinuation in up to one-third of patients with MDD [13, 14, 17]. Despite these clinical impacts, gaps in our knowledge regarding EB in major depression remain, particularly concerning patients in remission or those with mild-to-moderate depression and a history of childhood trauma.
This study was conducted to explore the prevalence of EB in patients with remitted or mild to moderate depression, and to examine the association between EB and childhood trauma. We hypothesized that the prevalence of EB in patients with remitted and mild-to-moderate depression would be approximately 40–50%. Additionally, we postulated that the intensity of EB in remitted patients is significantly associated with childhood adverse experiences.
The sample size was calculated a priori based on the prevalence of EB of 46% among patients with MDD receiving treatment [13] with an estimated absolute error of 10%, and a power of 80%. Assuming a 10% rate of incomplete data, the required sample size was calculated to be 106 [18]. In addition, the expected correlation between EB and childhood adverse events was low (r = 0.3), therefore the sample size to test the second hypothesis was 85 [19]. Accordingly, the study set a sample size of 106 to adequately address both hypotheses.
Ethic approval and consent to participate
This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and relevant institutional guidelines for research involving human participants. The study protocol was reviewed and approved by the Institutional Review Board/Ethics Committee of Center for Ethics in Human Research, Khon Kaen University under approval number #HE661181.
All participants were informed about the objectives, procedures, potential risks, and benefits of the study before enrollment. Participation was entirely voluntary, and written informed consent was obtained from each participant prior to data collection. For older participants who required assistance in reading or understanding the study information, the details were explained clearly by the research team, and adequate time was provided for questions before consent was obtained. Participants were assured that refusal to participate or withdrawal from study at any time would not affect their medical care or access to treatment. Personal identifying information was removed from the research database, and all data were coded and stored securely with access limited to authorized members of the research team only.
Methods
This cross-sectional study was conducted at a medical university hospital in Thailand. The study was carried out over 12 months, from October 2023 to November 2024. The study included patients aged 18–65 who were diagnosed with a mild to moderate depressive episode, defined by a Patient Health Questionnaire (PHQ-9) score of ≤ 18 during screening from routine outpatient visit. Participants had a pre-existing diagnosis of major depressive disorder (MDD), Bipolar I disorder (BPID), or persistent depressive disorder (PDD) based on DSM-5 criteria. After being assessed by psychiatrists for routine care using the Hamilton Depression Rating Scale (HAM-D), if the severity of symptoms was not severe, and non-suicidal then participants provided written informed consent. All patients had been on the same antidepressant regimen for at least one month. Individuals were excluded if their medical records indicated an intellectual disability or any pre-existing neurodevelopmental disorder.
Because the study involved assessment of depressive symptoms, participants who were found to have clinically significant depressive symptoms or strong suicidal idea/intention were advised to seek evaluation and appropriate management. When necessary, referral to a psychiatrist or mental health professional was arranged according to the clinical practice of the study setting. No experimental intervention was performed, and the study procedures were considered to involve minimal risk to participants.
After obtaining written informed consent, sociodemographic and clinical data were collected via interviews conducted by trained research assistants. Screening for emotional blunting was performed using a single question from the Oxford Depression Questionnaire (ODQ) probing for the emotional effects of antidepressants: “Emotional effects vary, but may include, for example, feeling emotionally ‘numbed’ or ‘blunted’ in some way; lacking positive emotions or negative emotions; feeling detached from the world around you; or ‘just not caring’ about things that you used to care about. Have you experienced such emotional effects during the last six weeks?” Following this probing question, all participants self-completed the ODQ and the Adverse Childhood Experiences (ACE) Questionnaire.
Measurements
Oxford depression questionnaire (ODQ)
The ODQ is a 26-item self-report scale specifically designed to measure emotional blunting—the feeling of being emotionally “numb” or “dulled.” The ODQ is divided into four main dimensions: General Reduction (GR), Reduction in Positive Emotion (RP), Emotional Detachment (ED), and Not Caring (NC). An optional fifth dimension assesses Antidepressant as Cause (AC). It is scored by summing responses on a 5-point Likert scale, where each item is rated from 1 to 5 based on the level of agreement: 1 = Disagree; 2 = Disagree a little; 3 = Neither agree nor disagree; 4 = Agree a little; and 5 = Agree. Higher scores indicate a greater intensity of emotional blunting, categorized as follows: 26–52 (minimal), 53–78 (mild), 79–104 (moderate), and 105–130 (severe) [20]. The author obtained permission from Oxford University Innovation Limited to translate the ODQ into the Thai language, strictly following guidelines for cultural validation. The Thai versions of the ODQ-26 and ODQ-20 demonstrated Cronbach’s alpha values of 0.886 and 0.868, respectively, within the population of this study.
Adverse childhood experiences (ACE)
The Adverse Childhood Experiences (ACE) questionnaire is a 26-item self-report tool used to assess major types of childhood trauma, including emotional abuse, sexual abuse, physical neglect, emotional neglect, and domestic violence. This study utilized the original CDC-Kaiser ACE questionnaire, which quantifies the frequency of each trauma type. Most items use a 5-point Likert scale ranging from 0 (never) to 4 (very frequent), where higher scores indicate a greater frequency of abuse or neglect. However, four items related to sexual abuse and six items related to household dysfunction use a dichotomous rating (0 = no, 1 = yes) [21]. Additionally, five items assessing emotional neglect use reverse scoring; for these items, a higher sum score indicates frequent emotional support from the family, hereafter referred to as “emotional support”. The Thai version of the original CDC-Kaiser ACE questionnaire has been culturally validated with a Cronbach’s Alpha of 0.856 [22].
Hamilton depression rating scale (HAMD-17)
The Hamilton Depression Rating Scale (HDRS or HAMD) is a clinician-administered psychometric questionnaire. This study utilized the 17-item version (HAMD-17), which employs two distinct scoring systems. A 5-point Likert scale (0–4) ranging from “absent” (0) to “very severe” [4] for symptoms that allow for more nuanced measurement, such as depressed mood, guilt, and impaired work and activities. A 3-point Likert scale (0–2): Ranging from “absent” (0) to “present” [2] for symptoms that are more difficult to quantify, such as weight loss, insomnia, and gastrointestinal symptoms. The total score is categorized as follows: 0–7 (remission), 8–13 (mild), 14–18 (moderate), and 19 or higher (severe). The Thai version of HAMD was validated previously with Cronbach’s alpha value of 0.858 [23].
The patient health questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is one of the most common and widely used self-report tools for screening, diagnosing, and measuring the severity of depression. It asks the patient to rate how often they have been bothered by 9 specific symptoms over the past two weeks. Each of the 9 items is scored from 0 to 3 based on frequency: 0 = Not at all; 1 = Several days; 2 = More than half the days; 3 = Nearly every day. The total score is a sum from every item; the higher score indicates greater severity of depressive symptoms. This study used PHQ-9 as a screening tool to capture patients with mild – moderate depression, which the total score falls within the range of 0–18. The Thai version of PHQ-9 was validated previously with Cronbach’s alpha value of 0.79 [24].
Statistical analysis
Data analyses used SPSS version 28. Descriptive statistics used percentages for categorical variables and means ± standard deviations (SD). Analytical statistics for differences between two groups used the independent t-test, and the Pearson correlation coefficient for correlation analyses. Statistical significance was set at a p-value less than 0.05.
Results
A total of 106 participants were recruited and completed the study with demographic data detailed in the Table 1. Prevalence of EB from the single-question screening and a cut-off of ODQ ≥ 26 were 55.6%, and 89%, respectively. Using the single-question screening, the prevalence of EB in MDD, PDD, and BPD were 50.8%, 63.2%, and 61.5%, respectively. The prevalence was not associated with diagnostic groups (p > 0.05). Among remitters (n = 53; 50%), whose HAM-D score ≤ 7, the prevalence of EB was significantly lower than non-remitters (45.3% vs. 66%, chi’s square = 4.97, p < 0.05). Regarding ODQ score 67 participants (63.2%) had minimal EB, 38 had mild EB (35.8%), and 1 had severe EB (0.9%). For the total ODQ scores, both ODQ-26 and ODQ-20, non-remitters had significantly higher scores than remitters (both p < 0.05). There were 2 domains, not care (NC), and reduction in positive emotion (RP), which scores were significantly higher in non-remitters (both p < 0.05). All patients were on at least one antidepressant, and 97 (91.5%) participants reported score from antidepressant as cause (AC) domain greater than zero. Mean of the ACE total scores were not significantly different between remitters and non-remitters (Xremitters = 17.5 ± 6.5 vs. Xnon−remitters 19.4 ± 6.5, df = 104, p = 0.131). The means from all ACE subscale scores, were not different between remitters and non-remitters (all p > 0.05).
Table 1Demographic data of the participants
Demographic (N = 106) Mean ± SD, N (%)
Age (years) 29 ± 9.97
Sex (female) 77 (72.6%)
Education (years) 15.0 ± 2.0
Employment 67 (63%)
Monthly income (USD) 738 ± 1,833
Diagnoses
-Major Depressive Disorder
-Persistent Depressive Disorder
-Bipolar Disorder
61 (57.5%)
19 (17.9%)
26 (24.6%)
Duration of illness (years) 2.2 ± 0.8
Number of total mood episodes 4 ± 3.3
HAM-D
-remission (0–7)
-mild depression (8–16)
-moderate depression (17–23)
8.1 ± 5.9
53 (50%)
40 (37.7%)
13 (12.3%)
ODQ
-not caring
-general reduction
-emotional detachment
-reduction of positive emotion
-antidepressant as cause
46 ± 17.1
9 ± 4.7
11.2 ± 3.5
7.5 ± 5.2
10.9 ± 5.2
7.8 ± 5.3
ACE
emotional abuse
-physical abuse
-domestic violence
-physical neglect
-sexual abuse
-sum of abuse + violence + neglect
-emotional support
3.2 ± 2.3
1.6 ± 1.8
1.3 ± 2.9
3.9 ± 3.2
0.5 ± 1.1
10.5 ± 7.5
12.3 ± 5.0
HAM-D = Hamilton depressive symptoms rating scale; ODQ = Oxford Depression Questionnaire; ACE = Adverse Childhood Experiences
Table 2Pearson’s correlation coefficients between the subscale scoresfrom oxford depression questionnaire (ODQ) and adverse childhood experiences (ACE)
N = 106 Adverse Childhood Events
Emotional abuse Physical abuse Sexual abuse Emotional Support Domestic Violence Physical Neglect
Oxford Depression Questionnaire
Not caring 0.259** 0.208* 0.023 -0.25** 0.05 0.103
General reduction 0.129 0.039 0.023 -0.110 0.179 0.199*
Emotional detachment 0.132 0.110 -0.11 -0.118 0.16 0.09
Reduction of positive emotion -0.033 0.044 -0.35 -0.114 0.004 -0.006
Antidepressant as cause 0.185 0.066 0.041 -0.020 0.059 0.109
Total score 0.184 0.125 -0.016 -0.168 0.123 0.132
*P < 0.05; ** p < 0.01
Correlation analysis using Pearson’s correlation coefficients between ODQ and demographic variables showed that there were significant correlations between the total ODQ score and following demographic and clinical variables: HAM-D score (r = 0.232, p = 0.016), PHQ-9 score (r = 0.36, p < 0.001), and number of recurrent episodes (r = 0.268, p = 0.035). The HAM-D score was significantly correlated with both the NC domain (r = 0.287, p = 0.003), and the RP domain (r = 0.378, p < 0.001) scores of the ODQ. Similarly, the PHQ-9 score was significantly correlated with the NC domain (r = 0.409, p < 0.001), and the RP domain (r = 0.568, p < 0.001) scores of the ODQ. Only the PHQ-9 score had a statistically significant correlation with physical abuse subscale score (r = 0.254, p = 0.09).
Analysis of the total population found that the NC domain score of the ODQ was significantly correlated with the following ACE subscale scores: emotional abuse (r = 0.259, p = 0.007); physical abuse (r = 0.208, p = 0.033); and emotional support (r = -0.25, p = 0.01). Additionally, the General Reduction (GR) domain score was significantly correlated with the ACE physical neglect score (r = 0.199, p = 0.041), and the RP domain score of the ODQ was significantly correlated with the number of recurrent episodes (r = 0.347, p = 0.006). After controlling the AC domain score using partial correlation analysis, the only statistically significant correlation was the negative correlation between the NC domain score of the ODQ and the ACE emotional support score (r = -0.233, p = 0.018). All correlation coefficients were detailed in Table 2.
Among remitters, there were no significant correlations between the total ODQ score and either HAM-D, or PHQ-9 scores. Neither the PHQ-9 nor the HAM-D scores were correlated with any ACE subscale score. However, the NC score was significantly correlated with the following ACE scores: emotional abuse (r = 0.304, p = 0.027), and emotional support (r = -0.328, p = 0.017). Furthermore, emotional detachment (ED) score was significantly correlated with the ACE domestic violence score (r = 0.286, p = 0.038).
Discussion
To the best of our knowledge, this study was the first study which explores the prevalence of emotional blunting in patients with mild to moderate major depressive episode from MDD, PDD and Bipolar I disorder and its associated factors. Emotional blunting was found in more than half of the patients, regardless of the diagnosis. This study found that the intensity of this emotional phenomenon was correlated with severity of adverse childhood experiences while it was not correlated with the severity of depressive symptoms in the patients with remitted depression. We discussed our findings and compared them with literature below.
Emotional blunting was highly prevalent in this study, with rates consistent with previous research using the ODQ ranging from 25% to 91.0% [12, 15, 16, 20]. These variations in prevalence across studies can be attributed to several factors, including measurement differences, the specific characteristics of mood disorders, and cultural nuances. First, there are no universally accepted diagnostic criteria or standardized measurements for emotional blunting. Even when using the ODQ, utilizing a single screening question yields different prevalence rates compared to using established cut-off scores [20]. Second, the variety of tools used across literature likely explains these discrepancies. The ODQ was the first scale developed specifically for this purpose; however, it captures prevalence through a single item, while 26 items are used to assess severity and subdomains. Other scales, such as the Snaith–Hamilton Pleasure Scale (SHAPS) or the anhedonia subscales of the HAM-D and Montgomery-Asberg Depression Rating Scale (MADRS), may capture elements of emotional blunting, particularly anhedonia, but they lack the detail required to assess domains like emotional numbness and detachment from ODQ. Both the PHQ-9 and the HAM-D which this study used also were correlated with certain ODQ domains, particularly the NC and the RP. These findings suggest that traditional measurements for depressive disorders could partially capture EB. Third, cultural differences in the regions where these studies were conducted may influence reported prevalence. It is well known that the prevalence of major depression varies globally. For instance, many East Asian countries, such as Japan and Korea, report lower rates of depressive disorders compared to Western nations, yet they have significantly higher suicide rates. This discrepancy strongly suggests that coping styles and the clinical presentation of symptoms differ significantly across cultures.
Regarding population characteristics, most previous studies recruited only patients with MDD, excluding those with Bipolar I disorder (experiencing a depressive episode) or Persistent Depressive Disorder (PDD). This study included all three diagnostic groups and found no significant differences in prevalence between them. This finding contributes a vital piece of information to literature; emotional blunting appears to be a phenomenon linked to the polarity of the mood state rather than a specific diagnosis. While previous research found that emotional blunting occurs in both exacerbated and stabilized depressive episodes [10], our study focused on patients whose medication had been stable for at least one month. We found a significantly lower prevalence of emotional blunting in remitters compared to non-remitters. Furthermore, the severity of emotional blunting correlated with depressive symptom scores and the number of lifetime depressive episodes. These findings suggest that both the chronicity and severity of mood disorder influence the intensity of emotional blunting, even in a non-severely depressed population. In this context, emotional blunting likely represents a residual mood symptom rather than an acute manifestation of mood disturbance. However, since most participants were taking at least one antidepressant, we cannot rule out the possibility that the blunting was a side effect of the treatment itself. Nearly all participants subjectively attributed their emotional blunting to their medication—this is supported by previous studies associating the condition with SSRIs, SNRIs, and combination treatments involving antipsychotics [13, 14, 25].
The correlations found between frequency of ACE and EB in this study are noteworthy. All participants reported at least one ACEs, particularly a lack of emotional support, emotional abuse, and physical neglect. However, the frequency of ACEs, and emotional support were not different between remitters and non-remitters. The significant positive correlations between the NC subscale and both emotional and physical abuse, alongside the significant negative correlation with emotional support, indicate that frequent childhood traumas impact the “intensity of caring” in depressed patients. In addition, the positive correlation between the PHQ-9 and the physical abuse subscale suggests that the severity of depression was linked to the frequency of childhood physical abuse. Crucially, the correlations between emotional abuse, emotional support, and the NC domain remained significant even among remitters. These findings strongly suggest that emotional abuse and a lack of emotional support negatively impact attachment and decrease the ability to care about one’s surroundings. This is well-supported by existing preclinical and clinical data from both rodents and humans, that early adverse experiences disturb reward processes specifically affecting reward gauging, perception, and decision-making [26]. Furthermore, the significant positive correlation between the ED domain and the frequency of domestic violence among remitters suggests that childhood domestic violence can cause serious impairment to attachment. This may lead patients to feel “detached” from people and their environment, even when they are no longer symptomatically depressed. It is worth noting that no significant correlation was found between sexual abuse and any ODQ domain. This is likely due to the relatively low prevalence (25%) of reported sexual abuse in this study, whereas other ACE domains were reported in more than 60% of participants. Furthermore, the negative correlation between the NC domain and emotional support, after controlling for the AC domain score, strongly suggests that NC intensity may be independently driven by childhood trauma specifically, a lack of emotional support.
Taken altogether, childhood traumas have been consistently linked to mood disorders, particularly treatment-resistant depression [8]. ACEs negatively impact the developing brain especially the reward circuit. Given that the construct of emotional blunting relies heavily on the perception of pleasure, connection, and motivation, trauma-induced impairment of reward perception likely contributes to the diminished capacity for these emotional experiences.
Conclusion
In summary, this study found that emotional blunting is prevalent across remitted mood disorders, regardless of the operational definition used, and its severity correlates with a history of childhood adverse events. However, major limitations include the single-site cohort design, a relatively small sample size, the lack of quantified anxiety symptoms, and the absence of a remitted control group not taking antidepressants. Furthermore, as with other retrospective studies on childhood adversity, recall bias was unavoidable. Future research involving larger, multi-site populations and more rigorous methodologies, including potential treatment interventions, is needed to better understand this complex psychological symptom and its clinical implications.
References
1.Institute for Health Metrics and Evaluation (IHME)Global Burden of Disease Study 2021 (GBD 2021) United States Burden of Disease Forecasts 2022–2050 2024 Seattle, United States of AmericaInstitute for Health Metrics and Evaluation (IHME)Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2021 (GBD 2021) United States Burden of Disease Forecasts 2022–2050. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME); 2024.
2.Zhang Y Li Z Feng Q Xu Y Yu R Chen J Global, regional and national burdens of major depression disorders and its attributable risk factors in adolescents and young adults aged 10–24 years from 1990 to 2021 BMC Psychiatry 2025 25 1 399 10.1186/s12888-025-06772-w 40251551 PMC12007280 Zhang Y, Li Z, Feng Q, Xu Y, Yu R, Chen J, et al. Global, regional and national burdens of major depression disorders and its attributable risk factors in adolescents and young adults aged 10–24 years from 1990 to 2021. BMC Psychiatry. 2025;25(1):399.10.1186/s12888-025-06772-w PMC12007280 40251551
3.Rong J Wang X Cheng P Li D Zhao D Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study Br J Psychiatry 2025 227 4 688 97 10.1192/bjp.2024.266 39809717 Rong J, Wang X, Cheng P, Li D, Zhao D. Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. Br J Psychiatry. 2025;227(4):688–97.10.1192/bjp.2024.266 39809717
4.Lee E Jeong J Hong S Lee S Kong J Lee H Global Burden of Depressive Disorders, 1990–2021, During the COVID-19 Pandemic and Projections to 2050: A Global Burden of Disease Study 2021 Psychiatry Investig 2025 22 11 1277 89 10.30773/pi.2025.0211 41276792 PMC12646708 Lee E, Jeong J, Hong S, Lee S, Kong J, Lee H, et al. Global Burden of Depressive Disorders, 1990–2021, During the COVID-19 Pandemic and Projections to 2050: A Global Burden of Disease Study 2021. Psychiatry Investig. 2025;22(11):1277–89.10.30773/pi.2025.0211 PMC12646708 41276792
5.Brody DJ Hughes JP Depression Prevalence in Adolescents and Adults: United States, August 2021-August 2023 NCHS Data Brief 2025 527 1 10.15620/cdc/174579 PMC12400127 40839857 Brody DJ, Hughes JP. Depression Prevalence in Adolescents and Adults: United States, August 2021-August 2023. NCHS Data Brief. 2025;527:1.10.15620/cdc/174579 PMC12400127 40839857
6.Xiao F Liu F Wang Y Zhang Z Childhood trauma and depressive symptoms in college students: the mediating role of fear of happiness BMC Psychol 2026 14 1 186 10.1186/s40359-025-03925-0 41508038 PMC12882259 Xiao F, Liu F, Wang Y, Zhang Z. Childhood trauma and depressive symptoms in college students: the mediating role of fear of happiness. BMC Psychol. 2026;14(1):186.10.1186/s40359-025-03925-0 PMC12882259 41508038
7.Nanni V Uher R Danese A Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis Am J Psychiatry 2012 169 2 141 51 10.1176/appi.ajp.2011.11020335 22420036 Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry. 2012;169(2):141–51.10.1176/appi.ajp.2011.11020335 22420036
8.Williams LM Debattista C Duchemin AM Schatzberg AF Nemeroff CB Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression Transl Psychiatry 2016 6 5 e799 10.1038/tp.2016.61 27138798 PMC5070060 Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Transl Psychiatry. 2016;6(5):e799.10.1038/tp.2016.61 PMC5070060 27138798
9.Childhood Trauma Meta-Analysis Study GTreatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a systematic review and meta-analysis Lancet Psychiatry 2022 9 11 860 73 10.1016/S2215-0366(22)00227-9 36156242 Childhood Trauma Meta-Analysis Study G. Treatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a systematic review and meta-analysis. Lancet Psychiatry. 2022;9(11):860–73.10.1016/S2215-0366(22)00227-9 36156242
10.Christensen MC Ren H Fagiolini A Emotional blunting in patients with depression. Part I: clinical characteristics Ann Gen Psychiatry 2022 21 1 10 10.1186/s12991-022-00387-1 35379283 PMC8981644 Christensen MC, Ren H, Fagiolini A. Emotional blunting in patients with depression. Part I: clinical characteristics. Ann Gen Psychiatry. 2022;21(1):10.10.1186/s12991-022-00387-1 PMC8981644 35379283
11.Christensen MC Ren H Fagiolini A Emotional blunting in patients with depression. Part III: relationship with psychological trauma Ann Gen Psychiatry 2022 21 1 21 10.1186/s12991-022-00395-1 35729621 PMC9210060 Christensen MC, Ren H, Fagiolini A. Emotional blunting in patients with depression. Part III: relationship with psychological trauma. Ann Gen Psychiatry. 2022;21(1):21.10.1186/s12991-022-00395-1 PMC9210060 35729621
12.Kwan YIC, Fung CS, Lee SKW, Lui VWY, Cheng CPW. Emotional blunting in Hong Kong patients with major depressive disorder treated with vortioxetine: a naturalistic observational study. Biomedicines. 2026;14(2).10.3390/biomedicines14020270 PMC12937620 41751169
13.Goodwin GM Price J De Bodinat C Laredo J Emotional blunting with antidepressant treatments: A survey among depressed patients J Affect Disord 2017 221 31 5 10.1016/j.jad.2017.05.048 28628765 Goodwin GM, Price J, De Bodinat C, Laredo J. Emotional blunting with antidepressant treatments: A survey among depressed patients. J Affect Disord. 2017;221:31–5.10.1016/j.jad.2017.05.048 28628765
14.Bolling MY Kohlenberg RJ Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction Psychother Psychosom 2004 73 6 380 5 10.1159/000080392 15479994 Bolling MY, Kohlenberg RJ. Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom. 2004;73(6):380–5.10.1159/000080392 15479994
15.Kikuchi T Iga JI Hattori A Tokuda F Moriguchi Y Hoshino T Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder Neuropsychiatr Dis Treat 2025 21 841 54 10.2147/NDT.S485109 40313313 PMC12045556 Kikuchi T, Iga JI, Hattori A, Tokuda F, Moriguchi Y, Hoshino T. Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder. Neuropsychiatr Dis Treat. 2025;21:841–54.10.2147/NDT.S485109 PMC12045556 40313313
16.Nazir N Nazir D Mehmood R Wani ZA Raj R Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study Ind Psychiatry J 2026 35 1 54 9 10.4103/ipj.ipj_201_25 41726290 PMC12923221 Nazir N, Nazir D, Mehmood R, Wani ZA, Raj R. Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study. Ind Psychiatry J. 2026;35(1):54–9.10.4103/ipj.ipj_201_25 PMC12923221 41726290
17.Rosenblat JD Simon GE Sachs GS Deetz I Doederlein A DePeralta D Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression J Affect Disord 2019 243 116 20 10.1016/j.jad.2018.09.027 30241026 Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, et al. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord. 2019;243:116–20.10.1016/j.jad.2018.09.027 30241026
18.Rogan WJ Gladen B Estimating prevalence from the results of a screening test Am J Epidemiol 1978 107 1 71 6 10.1093/oxfordjournals.aje.a112510 623091 Rogan WJ, Gladen B. Estimating prevalence from the results of a screening test. Am J Epidemiol. 1978;107(1):71–6.10.1093/oxfordjournals.aje.a112510 623091
19.Hulley SB Cummings SR Browner WS Grady DG Newman TB Designing Clinical Research 2013 4PhiladelphiaLippincott Williams & WilkinsHulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing Clinical Research. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
20.Christensen MC Fagiolini A Florea I Loft H Cuomo A Goodwin GM Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting J Affect Disord 2021 294 924 31 10.1016/j.jad.2021.07.099 34378539 Christensen MC, Fagiolini A, Florea I, Loft H, Cuomo A, Goodwin GM. Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting. J Affect Disord. 2021;294:924–31.10.1016/j.jad.2021.07.099 34378539
21.Felitti VJ Anda RF Nordenberg D Williamson DF Spitz AM Edwards V Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study Am J Prev Med 1998 14 4 245 58 10.1016/S0749-3797(98)00017-8 9635069 Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245–58.10.1016/s0749-3797(98)00017-8 9635069
22.Rungmueanporn L Buathong N Chandarasiri P Wittayasai W Development of the Adverse Childhood Experiences (ACE) Questionnaire Thai version Chula Med Bull 2019 1 3 251 60 Rungmueanporn L, Buathong N, Chandarasiri P, Wittayasai W. Development of the Adverse Childhood Experiences (ACE) Questionnaire Thai version. Chula Med Bull. 2019;1(3):251–60.
23.Lotrakul M Sukanich P Development of the Thai Depression Inventory J Med Assoc Thai 1999 82 12 1200 7 10659561 Lotrakul M, Sukanich P. Development of the Thai Depression Inventory. J Med Assoc Thai. 1999;82(12):1200–7.10659561
24.Lotrakul M Sumrithe S Saipanish R Reliability and validity of the Thai version of the PHQ-9 BMC Psychiatry 2008 8 46 10.1186/1471-244X-8-46 18570645 PMC2443128 Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8:46.10.1186/1471-244X-8-46 PMC2443128 18570645
25.Read J Williams J Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects Curr Drug Saf 2018 13 3 176 86 10.2174/1574886313666180605095130 29866014 Read J, Williams J. Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects. Curr Drug Saf. 2018;13(3):176–86.10.2174/1574886313666180605095130 29866014
26.Hanson JL Williams AV Bangasser DA Pea CJ Impact of Early Life Stress on Reward Circuit Function and Regulation Front Psychiatry 2021 12 744690 10.3389/fpsyt.2021.744690 34744836 PMC8563782 Hanson JL, Williams AV, Bangasser DA, Pea CJ. Impact of Early Life Stress on Reward Circuit Function and Regulation. Front Psychiatry. 2021;12:744690.10.3389/fpsyt.2021.744690 PMC8563782 34744836
Come citare questo studio
Narak Chadbunchachai, Papan Vadhanavikkit, Sirinapa Aphisitphinyo, Pattharee Paholpak, Nawanant Piyavhatkul, Parinda Pienroj, Pongsatorn Paholpak. (2026). Prevalence of emotional blunting and its association with childhood adverse experiences in depressive episodes.. BMC psychiatry. DOI: 10.1186/s12888-026-08518-8
Consulta la pubblicazione originale ↗